PJA2 (Praja Ring Finger Ubiquitin Ligase 2) Activators are a class of small molecules and compounds that have garnered significant attention in the field of molecular biology and cellular regulation. PJA2, a member of the RBR E3 ubiquitin ligase family, plays a crucial role in the ubiquitin-proteasome system (UPS) and is responsible for the targeted degradation of specific proteins within a cell. Activators of PJA2 are designed to modulate the activity of this ligase, leading to the increased ubiquitination and subsequent degradation of specific target proteins. These compounds are of particular interest in the study of protein turnover, cellular homeostasis, and the regulation of critical cellular processes.
PJA2 activators function by binding to the PJA2 protein, often through specific allosteric sites, which induces conformational changes in the ligase. This conformational shift enhances the binding affinity between PJA2 and its target proteins, promoting their ubiquitination and subsequent degradation. By leveraging PJA2 activators, researchers can gain insights into the intricate mechanisms underlying protein degradation and its role in cellular functions. Understanding the selectivity and specificity of these activators is of paramount importance, as it allows for the precise control of the UPS, paving the way for innovative studies in cell biology, targeted protein degradation, and the potential development of novel approaches for modulating specific cellular pathways. Consequently, PJA2 activators hold immense promise for advancing our knowledge of protein regulation and are valuable tools for investigating the broader landscape of intracellular processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Enhances ubiquitin-mediated proteolysis and may indirectly spark PJA2 activation by regulating the availability of ubiquitin for its ubiquitination targets. | ||||||
(–)-Nutlin-3 | 675576-98-4 | sc-222086 sc-222086A | 1 mg 5 mg | $122.00 $219.00 | 2 | |
Inhibits the MDM2 ubiquitin ligase, indirectly provoking PJA2 activation by potentially influencing the stability and activity of PJA2 substrates, such as p53. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
An HSP90 inhibitor that indirectly galvanizes PJA2 activation by modulating the stability and function of client proteins that may be subject to PJA2-mediated ubiquitination. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that indirectly stimulates PJA2 activation by influencing downstream signaling pathways, which may intersect with PJA2-associated processes. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
Acts as an oxygen radical scavenger, indirectly inciting PJA2 activation by potentially modulating cellular signaling pathways that intersect with PJA2 regulation. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
An Nrf2 activator that indirectly encourages PJA2 activation by regulating the expression of antioxidant proteins, potentially impacting pathways related to PJA2. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $131.00 $651.00 | 7 | |
Another mTOR stimulant that indirectly kindles PJA2 activation by modulating downstream signaling pathways, which may intersect with PJA2-associated processes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase (HDAC) stimulant that indirectly incites PJA2 activation by modulating gene expression and potentially affecting PJA2 substrates. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Modulates autophagy and cellular processes related to protein degradation, indirectly animating PJA2 activation by influencing the stability and degradation of proteins that PJA2 may target. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
An agonist of PPAR-delta, which can indirectly enliven PJA2 activation by affecting nuclear receptor-mediated pathways and their potential interactions with PJA2-regulated processes. | ||||||